Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
about
Acquired subglottic stenosis caused by methicillin resistant Staphylococcus aureus that produce epidermal cell differentiation inhibitorA Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in JapDetection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndromeEarly and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells.New football boots and toxic shock syndromeHuman leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndromeHealthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution.Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.Unusual staphylococcal toxic shock syndrome presenting as a scarlet-like fever.Staphylococcal exanthematous disease in a newborn due to a virulent methicillin-resistant Staphylococcus aureus strain containing the TSST-1 gene in Europe: an alert for neonatologists.Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigenOverall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus.Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards.HLA-DR polymorphisms influence in vivo responses to staphylococcal toxic shock syndrome toxin-1 in a transgenic mouse model.Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood.Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice.Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan.The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines.Two-dimensional analysis of exoproteins of methicillin-resistant Staphylococcus aureus (MRSA) for possible epidemiological applications.An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit.Tracheoplasty using the thymus against tracheo-esophageal fistula due to necrotizing tracheobronchitis in a very low birth weight infant.Diagnostic value of Vbeta2-positive T-cell expansion in toxic shock syndrome.Neonatal toxic shock syndrome-like exanthematous disease (NTED).Genetic basis of neonatal methicillin-resistant Staphylococcus aureus in Japan.Foreword: current status of MRSA infections in neonatal medicine in Japan.Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals.Postpartum Methicillin-Resistant Toxic Shock Syndrome Caused by a Perineal Infection
P2860
Q28345311-F173C523-4310-4583-8815-7DFEEB10AD50Q30350993-FC2DBBDE-A0F3-4A20-9BBC-43AC37EDAE29Q30353240-616D898C-7E95-48AB-B841-8C8848C12513Q30433993-4B10C3C9-9695-4AC3-B7C2-EFC9467B641DQ33815281-455FDF62-0D06-4AC0-9831-07D3B76D1B19Q34219221-19362E34-A497-4BF5-A18F-8CCD2B4D45B2Q34669763-8E20F3AC-0034-448F-88EE-57C565A0FABDQ35071467-22520774-DF4E-413D-B051-9598F1486F02Q35654266-A59DC4F5-3CCC-480E-A012-305277B17372Q35690743-6F475515-1EEF-476A-A9FA-156912509138Q36111916-94078F25-0014-4A85-B456-96FCA03FBDF8Q36892034-66B8E8A6-98FB-41C2-BF50-F360D74A69D9Q37271740-69BAFC1A-9287-495D-8A46-AC3D5D68DA79Q38137242-7F2CF389-CEBB-411A-B834-E094A6DAC432Q39789881-92C7F897-3E5F-45B3-9551-681B93A5658FQ40445297-15B23062-C990-4BE2-8D9B-3111AD2173D1Q41983541-6E207F96-E393-442B-BD10-E8FEBD0364BBQ42705126-1698F544-852B-4FB3-950D-B057763E3EB9Q43601224-EEAAADD4-34DE-4FBA-8E2E-6837EE93599FQ43660021-256BEE98-CA72-416E-94D2-6F9AABA771FEQ43929737-4C45DD92-B1A9-4C3A-BEE0-214374858505Q44025341-5B33C9E6-4BBF-4C33-929E-95FBBB79A5B7Q47179833-B6C72A32-E46D-44F3-8F7B-31FC43992B98Q50898470-6860B55E-F4B1-4B9F-B2C5-638E00E7FF6CQ53933013-B1E76577-2F02-4753-86C3-9BEED1F08981Q53933021-B578DD14-5031-40B8-BF9A-E8E90285C21EQ53933025-C1C8546D-C725-453E-A850-9398DC32BD5FQ54379705-6742B965-FDFB-4E7C-BBB6-161CB11AD694Q58603951-75C4410F-FB21-40C8-B1EE-6368E147548D
P2860
Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Exanthematous disease induced ...... in the early neonatal period.
@ast
Exanthematous disease induced ...... in the early neonatal period.
@en
type
label
Exanthematous disease induced ...... in the early neonatal period.
@ast
Exanthematous disease induced ...... in the early neonatal period.
@en
prefLabel
Exanthematous disease induced ...... in the early neonatal period.
@ast
Exanthematous disease induced ...... in the early neonatal period.
@en
P2093
P1433
P1476
Exanthematous disease induced ...... in the early neonatal period.
@en
P2093
P304
P356
10.1016/S0140-6736(97)11125-4
P407
P577
1998-05-01T00:00:00Z